Table 4.
AUC | 95% CI | p | Youden index | Criterion | Sensitivity % | Specificity % | |
---|---|---|---|---|---|---|---|
Age (years) | 0.767 | 0.669–0.847 | 0.0001 | 0.4460 | > 49 | 71.4 | 73.2 |
Male sex | 0.620 | 0.515–0.717 | 0.0942 | 0.2404 | + | 64.3 | 59.8 |
eGFR (mL/min/1.73 m2) | 0.749 | 0.650–0.832 | 0.0003 | 0.4007 | ≤ 69.0 | 57.1 | 82.9 |
hs-TnI (pg/mL) | 0.878 | 0.795– 0.936 | < 0.0001 | 0.7596 | > 8.0 | 85.7 | 90.2 |
NT-proBNP (pg/mL) | 0.834 | 0.744–0.902 | < 0.0001 | 0.5906 | > 158 | 78.6 | 80.5 |
LV hypertrophy | 0.830 | 0.745–0.915 | < 0.0001 | 0.6603 | + | 92.9 | 73.2 |
LV mass index (g/m2.7) | 0.872 | 0.744–1.000 | < 0.0001 | 0.7700 | > 54.3 | 92.9 | 84.1 |
Left atrium volume (mL/m2) | 0.909 | 0.819–0.999 | < 0.0001 | 0.7247 | > 43 | 78.6 | 93.9 |
E/Ea | 0.925 | 0.845–1.000 | < 0.0001 | 0.8084 | > 12.8 | 85.7 | 95.1 |
LV ejection fraction (%) | 0.708 | 0.512–0.904 | 0.0372 | 0.4617 | ≤ 57 | 57.1 | 89.0 |
GLS (%) | 0.848 | 0.756–0.940 | < 0.0001 | 0.5767 | > -15.5 | 85.7 | 71.9 |
MEE index (mL/s per g) | 0.858 | 0.740–0.977 | < 0.0001 | 0.6969 | ≤ 0.26 | 92.9 | 76.8 |
GWI (mmHg%) | 0.892 | 0.766- 1.000 | < 0.0001 | 0.7247 | ≤ 1148 | 78.6 | 93.9 |
GCW (mmHg%) | 0.908 | 0.797–1.000 | < 0.0001 | 0.7944 | ≤ 1513 | 92.9 | 86.6 |
GWW (mmHg%) | 0.812 | 0.697–0.928 | < 0.0001 | 0.4669 | > 83 | 85.7 | 61.0 |
GWE (%) | 0.915 | 0.830–1.000 | < 0.0001 | 0.7108 | ≤ 91 | 85.7 | 85.4 |
ROC receiver operating characteristic, AUC area underthecurve, CI confidence interval, eGFR estimated glomerular filtration rate, hs-TnI high-sensitivity troponin I, NT-proBNP N-terminal prohormone of Brain Natriuretic Peptide, LV left ventricular, E/Ea ratio the ratio of mitral (E) to mitral annulus (Ea) early diastolic peak velocity, MEE mechano-energetic efficiency, GWE global work efficiency, GWI global work index, GCW global constructive work, GWW global wasted work